Acute myeloid leukemia (AML) continues to be the most common acute leukemia in adults, with an incidence of 5.5 cases per 100,000 persons annually. As such, more education is needed on key topics including use of induction therapy in the non-elderly population, treating suboptimal response to induction therapy, best practices for measurable (or minimal) residual disease assessment, and proper use of maintenance therapy..The goal of this educational curriculum, Turning Complexity into Clarity in AML, is to establish impactful small group interactions between members of the AML care team that will, through a variety of collaborative educational experiences, help them in learning and sharing best practices that will improve outcomes for patients with AML.

CME/CE Accreditation Information

With the increase in the lifespan of patients with beta thalassemia and demographic shifts in the U.S., hematologists are treating more patients with this condition. As such, more education is needed on key topics including disease fundamentals, transitioning patients to adult care, new and emerging therapies, and issues around transfusion.The goal of this educational curriculum, Improving Beta-thalassemia Outcomes, is to establish impactful small group interactions between members of the hematology care team that will, through a variety of collaborative educational experiences, help them to improve disease management and care coordination to yield better outcomes for their patients with Beta-thalassemia.

CME/CE Accreditation Information